United States-based pharmaceutical company AbbVie Inc. (NYSE: ABBV) announced on Thursday its quarterly cash dividend.
The company has declared dividend of USD1.41 per share.
The cash dividend will be paid to shareholders of record at 15 July 2022 on 15 August 2022.
AbbVie said that its mission is to discover and deliver innovative medicines across several key therapeutic areas such as immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Biocorp and Merck KGaA, Darmstadt, Germany Partner on Smart Drug Delivery
BIOCORP and Germany's Merck sign smart drug delivery agreement
Pfizer to supply up to 6 million Paxlovid treatments to Global Fund
Common and Affordable Drug Can Drastically Reduce COVID Complications, Study Shows
Moderna sues Pfizer and BioNTech over COVID-19 vaccine patents
Bavarian Nordic signs APAC order for smallpox/monkeypox vaccine doses